¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (2ÀÏÂ÷) : 2023-04-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (2ÀÏÂ÷) : 2023-04-28
±³À°ÀÏÀÚ : 2023-04-28
±³À°Àå¼Ò : ¿öÄ¿Èú È£ÅÚ ¼­¿ï (ÁöÇÏ1Ãþ, ÁöÇÏ2Ãþ, 1Ãþ, 4Ãþ)

±³À°ÁÖÁ¦ : ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : À̽ÿÂ
¿¬¶ôó : 02-3452-7291  

À̸ÞÀÏ : gbcc@intercom.co.kr
±³À°Á¾·ù : ¿Ü°ú, ¼ºÇü¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, ÀÇÇб³À°, ÀÇ·á°æ¿µ

Âü¼®¿¹»óÀÎ : 1700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 75 ½Ã°£ 25ºÐ

¼¼ºÎ¼ö°­·á :800,000¿ø  

ºñ°í [Á¶±âµî·Ï(2022.11.01-2023.02.02)]Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSȸ¿ø) 400,000 Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSºñȸ¿ø) 500,000Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±ºÀÇ°ü/Çлý 150,000 [»çÀüµî·Ï(2023.02.03-2023.04.05)]Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSȸ¿ø) 480,000 Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSºñȸ¿ø) 600,000Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±ºÀÇ°ü/Çлý 200,000 [ÇöÀåµî·Ï(2023.04.27-2023.04.29)]Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSȸ¿ø) 640,000 Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSºñȸ¿ø) 800,000Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±ºÀÇ°ü/Çлý 250,000 *http://gbcc.kr/Contents.asp?LoadPage=Instruction&Tap=B

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 08:30~09:15 [Satellite Symposium 2] Palbociclib: Added Value of Long-term Efficacy, Safety and Real-world Data Kyung-Hun Lee(Seoul National Univ. Hospital, Korea)

ÈÞ½Ä 04¿ù 28ÀÏ 09:15~09:30 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 09:30~10:15 [Plenary Lecture 3] Genomic Biology of Triple Negative Breast Cancer Edison Liu(The Jackson Laboratory, U.S.A.)

ÈÞ½Ä 04¿ù 28ÀÏ 10:15~10:30 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 10:30~11:45 [Symposium 5: Single Cell Proteogenomic and Translational Research in Breast Cancer] Single Cell Genomics in Breast Cancer Amos Lee(Seoul National Univ., Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 10:30~11:45 [Symposium 5: Single Cell Proteogenomic and Translational Research in Breast Cancer] Single Cell Proteomic Technology and Future Junho Park(CHA Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 10:30~11:45 [Symposium 5: Single Cell Proteogenomic and Translational Research in Breast Cancer] Single Cell Genomics of Circulating Tumor Cells in Breast Cancer Andi K. Cani(Univ. of Michigan, U.S.A.)

Åä·Ð 04¿ù 28ÀÏ Vista 3 10:30~11:45 [Panel Discussion 4: Treatment Dilemma in the Management of Breast Cancer] Clinical Staging in Breast Cancer Patients Undergoing Neoadjuvant Treatment Han-Byoel Lee(Seoul National Univ. Hospital, Korea)

Åä·Ð 04¿ù 28ÀÏ Vista 3 10:30~11:45 [Panel Discussion 4: Treatment Dilemma in the Management of Breast Cancer] Can cT3/4 Breast Cancer be Safely Treated with Breast Conserving Surgery After Neoadjuvant Treatment? Mehra Golshan(Yale School of Medicine, U.S.A.)

Åä·Ð 04¿ù 28ÀÏ Vista 3 10:30~11:45 [Panel Discussion 4: Treatment Dilemma in the Management of Breast Cancer] Is Sentinel LN Biopsy Feasible in Clinical N2-3 Patients After Neoadjuvant Treatment? Jean-Francois Boileau(Jewish General Hospital, McGill Univ., U.S.A.)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 10:30~11:45 [Education Session 4: Update of HER2+ Breast Cancer Treatment] Systemic Treatment for HER2-positive Early Breast Cancer Jee Hung Kim(Yonsei Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 10:30~11:45 [Education Session 4: Update of HER2+ Breast Cancer Treatment] Systemic Treatment for HER2-positive Metastatic Breast Cancer Soo Chin Lee(National Univ. Cancer Institute, Singapore)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 10:30~11:45 [Education Session 4: Update of HER2+ Breast Cancer Treatment] Overview and Management of Adverse Events of Anti-HER2 ADCs Makiko Ono(The Cancer Institute Hospital of JFCR, Japan)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] COMPARATIVE MICROBIOME ANALYSIS OF THE CONTRACTED BREAST CAPSULE USING NEXT GENERATION SEQUENCING Tae Hyun Park(Kyungpook National Univ. School of Medicine, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] FACTORS RELATED TO PREGNANCY RATE AND TIMING AFTER BREAST CANCER TREATMENT IN YOUNG PATIENTS. Young-Jin Lee(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] PRELIMINARY EFFICACY OF NEOADJUVANT NAB-PACLITAXEL AND PEMBROLIZUMAB-CONTAINING REGIMENS IN EARLY STAGED TRIPLE NEGATIVE BREAST CANCER (ETNBC) THERAPY Sum Lung Jeffrey Wong(Queen Mary Hospital, Hong Kong)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] DP103-REGULATED P53-SUMO/ACETYLATION SWITCH DETERMINES RESPONSE TO DOCETAXEL IN ER¥Á-POSITIVE BREAST CANCER Alan Prem Kumar(National Univ. of Singapore, Singapore)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] KEY REGULATORS OF CHOLESTEROL AND LIPID METABOLISM AGGRAVATE BREAST CANCER Sakshi Shukla(All India Institute of Medical Sciences, New Delhi, India)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] PATTERN AND COMPLICATION OF RECONSTRUCTED BREAST CANCER PATIENTS WHO RECEIVED POSTMASTECTOMY RADIOTHERAPY IN THE NATIONAL HEALTH INSURANCE SERVICE COHORT  Hyejo Ryu(Seoul National Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] MULTIDIMENSIONAL LONGITUDINAL ASSESSMENT OF TOXICITY AND COSMESIS AFTER HYPOFRACTIONATED WHOLE-BREAST RADIOTHERAPY FOR BREAST CANCER AMONG A PROSPECTIVE COHORT OF KOREAN WOMEN: A Nalee Kim(Samsung Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] IMPACT OF SURGICAL FACTORS ON AESTHETIC OUTCOME AFTER BREAST CONSERVATION THERAPY: A PROSPECTIVE COHORT STUDY Shraddha Kenekar(Tata Memorial Center, India)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 10:30~11:45 [Oral Presentation 5] BIODEGRADEBLE AND REDOX-RESPONSIVE NANOPARTICLE PLATFORM WITH TROP2 ANTIBODY LINKAGE FOR RNA INTERFERENCE TARGETING LNCRNA MNX1-AS1 TO REDUCE RADIO-RESISTANCE IN TRIPLE NEGATIVE BREAST CANCER Qingjian Li(Sun Yat-sen Memorial Hospital, China)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 10:30~11:45 [Nursing Session 1: The Managements for Cognitive Impairment Related to Breast Cancer] The Impact of Chemotherapy on Cognitive Impairments: Evidence and Implications Hee-Ju Kim(The Catholic Univ. of Korea, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 10:30~11:45 [Nursing Session 1: The Managements for Cognitive Impairment Related to Breast Cancer] The Cognitive Impairment in Breast Cancer Patients Undergoing Therapy Hyejin Cho(Ewha Womans Univ. Seoul Hospital, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 10:30~11:45 [Nursing Session 1: The Managements for Cognitive Impairment Related to Breast Cancer] Beneficial Effects of Exercise on Cancer-related Cognitive Impairment with Breast Cancer Patients Seung-Soo Baek(Sangmyung Univ., Korea)

ÈÞ½Ä 04¿ù 28ÀÏ 11:45~12:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 12:00~12:45 [Plenary Lecture 4] Breast-Cancer Related Lymphedema: Myths, Facts, Risk Factors and New Approach Alphonse Taghian(Massachusetts General Hospital, U.S.A.)

ÈÞ½Ä 04¿ù 28ÀÏ 12:45~13:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 13:00~13:45 [Satellite Symposium 3] Take Hope Further for HR+HER2-high-risk Early Breast Cancer Patients with Abemiciclib Nadia Harbeck(LMU Univ. Hospital, Germany)

ÈÞ½Ä 04¿ù 28ÀÏ 13:45~14:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 14:00~14:45 [Plenary Lecture 5] Escalation and De-escalation of Breast Cancer Treatment Michael Gnant(Medical Univ. of Vienna, Austria)

ÈÞ½Ä 04¿ù 28ÀÏ 14:45~15:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 15:00~16:15 [Symposium 6: The Role of Imaging in the Personalized Treatment] The Role of Imaging for the Management of DCIS Mami Iima(Kyoto Univ. Hospital, Japan)

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 15:00~16:15 [Symposium 6: The Role of Imaging in the Personalized Treatment] The Role of DW-MRI in the Personalized Screening and Diagnosis Savannah Partridge(Univ. of Washington, U.S.A.)

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 15:00~16:15 [Symposium 6: The Role of Imaging in the Personalized Treatment] Quantitative Imaging in Outcome Prediction of Breast Cancer Vivian Youngjean Park(Yonsei Univ. College of Medicine, Korea)

Åä·Ð 04¿ù 28ÀÏ Vista 3 15:00~16:15 [Panel Discussion 5: Locoregional Treatment for Advanced/Recurrent Breast Cancer] Surgical Extent After Neoadjuvant Chemotherapy Geok Hoon Lim(KK Women)

Åä·Ð 04¿ù 28ÀÏ Vista 3 15:00~16:15 [Panel Discussion 5: Locoregional Treatment for Advanced/Recurrent Breast Cancer] Role of Repeat Breast-conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence Andreas Karakatsanis(Uppsala Univ. Hospital, Sweden)

Åä·Ð 04¿ù 28ÀÏ Vista 3 15:00~16:15 [Panel Discussion 5: Locoregional Treatment for Advanced/Recurrent Breast Cancer] Radiation Therapy According to Residual Tumor Volume After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Sung-Ja Ahn(Chonnam National Univ. Medical School, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 15:00~16:15 [Education Session 5: Liquid Biopsy: New Era of Cancer Management] Basic Technology of Liquid Biopsy Eunhae Cho(GC Genome, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 15:00~16:15 [Education Session 5: Liquid Biopsy: New Era of Cancer Management] Clinical Utility of Detection of Early Recurrence or Minimal Residual Disease Using Liquid Biopsy in Early Breast Cancer Kan Yonemori(National Cancer Center Hospital, Japan)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 15:00~16:15 [Education Session 5: Liquid Biopsy: New Era of Cancer Management] Current Advances of Liquid Biopsy in Tumor Burden Dynamics, Response Monitoring and Prognostic Marker in Metastatic Breast Cancer Jisun Kim(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 15:00~16:15 [Nursing Session 2: Living and Care as Women with Hereditary Breast Cancer] An Overview of Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome Bom-Yi Lee(Daerim St. Mary)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 15:00~16:15 [Nursing Session 2: Living and Care as Women with Hereditary Breast Cancer] Genetic Counseling for Hereditary Breast Cancer Patients Ji Hye Yang(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 15:00~16:15 [Nursing Session 2: Living and Care as Women with Hereditary Breast Cancer] The Process of Choosing Cancer Risk-reducing Options in Women with Hereditary Breast Cancer: A Grounded Theory Study Sun-young Park(National Evidence-based Healthcare Collaborating Agency, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 15:00~16:40 [Endoscopic and Robotic Breast Surgery Session] Challenges of Robot Breast Surgery: Is there a Role for Robot Breast Surgery Outside of Clinical Trial? Moo Hyun Lee(Keimyung Univ. School of Medicine, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 15:00~16:40 [Endoscopic and Robotic Breast Surgery Session] Challenges of Endoscopic Breast Surgery: Is It Just a Bridge for Robot Breast Surgery? Chi Wei Mok(Changi General Hospital, Singhealth Duke NUS Breast Centre, Singapore)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 15:00~16:40 [Endoscopic and Robotic Breast Surgery Session] Current Status of Robot Breast Surgery Wen-Ling Kuo(Chang Gung Memorial Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 15:00~16:40 [Endoscopic and Robotic Breast Surgery Session] Robot Surgery for Breast Reconstruction Jesse Selber(Corewell Health, U.S.A.)

ÈÞ½Ä 04¿ù 28ÀÏ 16:15~16:30 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 16:30~17:45 [Symposium 7: PMRT/RNI in the Modern Era] Personalization of PMRT in the Modern Era Meena S. Moran(Yale School of Medicine, U.S.A.)

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 16:30~17:45 [Symposium 7: PMRT/RNI in the Modern Era] The Benefit of PMRT for Low Nodal Burden Breast Cancer in the Modern Treatment Era Kyung Hwan Shin(Seoul National Univ. Hospital, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 16:30~17:45 [Symposium 7: PMRT/RNI in the Modern Era] Incorporation of New Systemic Agents in Patients Treated with PMRT Alice Y. Ho(Duke Univ., U.S.A.)

Åä·Ð 04¿ù 28ÀÏ Vista 3 16:30~17:45 [Debate Session] Role of Platinum Agent in Early Triple Negative Breast Cancer - Pros. Jieun Lee(The Catholic Univ. of Korea, Seoul St. Mary)

Åä·Ð 04¿ù 28ÀÏ Vista 3 16:30~17:45 [Debate Session] Role of Platinum Agent in Early Triple Negative Breast Cancer - Cons. Min Hwan Kim(Yonsei Univ. College of Medicine, Korea)

Åä·Ð 04¿ù 28ÀÏ Vista 3 16:30~17:45 [Debate Session] Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Genomic risk Dae-Won Lee(Seoul National Univ. Hospital, Korea)

Åä·Ð 04¿ù 28ÀÏ Vista 3 16:30~17:45 [Debate Session] Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Clinical risk Tae-Kyung Robyn Yoo(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 16:30~17:45 [Education Session 6: Post-operative Management and Surveillance Strategies for Breast Cancer Patients] Surveillance Strategy Overview in Korea Hyeong-Gon Moon(Seoul National Univ. Hospital, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 16:30~17:45 [Education Session 6: Post-operative Management and Surveillance Strategies for Breast Cancer Patients] Post-operative Surveillance and Management for Breast Cancer Patients in Taiwan An-Chieh Feng(Tri-Service General Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 1 16:30~17:45 [Education Session 6: Post-operative Management and Surveillance Strategies for Breast Cancer Patients] The State-of-the-art Risk Prediction Tools and How They Apply to Asian Breast Cancer Screening Programs Jingmei Li(Genome Institute of Singapore, Singapore)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 16:30~18:00 [ABCN Business Meeting & Networking] Expert Panel Discussion: Navigating Challenges and Building Synergies in Breast Cancer Research: Insights from Experienced Experts Hee Kyung Ahn(Gachon Univ. Gil Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 16:30~18:00 [ABCN Business Meeting & Networking] Topic 1: The Art of Mentorship: Nurturing a Successful Career and Strategies for Effective Collaboration Jae Ho Jeong(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 16:30~18:00 [ABCN Business Meeting & Networking] Topic 2: Beyond Borders: Leveraging International Networks and Overcoming Practical Obstacles Yoo Seok Kim(Chosun Univ. Hospital, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 16:30~18:00 [ABCN Business Meeting & Networking] Proposal: Neoadjuvant Chemotherapy or Upfront Surgery in Clinically Node-positive, ER+HER2- Breast Cancer: A Multi-national Survey Study Sung Gwe Ahn(Gangnam Severance Hospital, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Art Hall 16:30~18:00 [ABCN Business Meeting & Networking] Product: Knowledge, Attitudes, and Behaviors toward Fertility Preservation in Patients with Breast Cancer: A Cross-Sectional Survey of Physicians Hee Jeong Kim(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 16:50~17:50 [OPBS Session] Oncoplastic breast surgery: Where are We? Ho Yong Park(Kyungpook National Univ. Chilgok Hospital, Korea)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 16:50~17:50 [OPBS Session] Advanced Surgical Technic for Successful OPBS in Breast Cancer Visnu Lohsiriwat(Siriraj Hospital, Mahidol Univ., Thailand)

±³À°½Ã°£ 04¿ù 28ÀÏ Walker Hall 2 16:50~17:50 [OPBS Session] Evaluation of Breast Symmetry and Cosmesis for Dense Breast Jung Ho Lee(The Catholic Univ. of Korea Bucheon St. Mary)

ÈÞ½Ä 04¿ù 28ÀÏ 17:45~18:00 Break ( )

±³À°½Ã°£ 04¿ù 28ÀÏ Vista 1+2 18:00~18:45 [Satellite Symposium 4] Optimal and Sequential Treatment Strategy for HR+ HER2- aBC Patients for Longer and Better Life Keun Seok Lee(National Cancer Center, Korea)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (2ÀÏÂ÷) : 2023-04-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2023 Ãá°è½ÉÆ÷Áö¾ö(2ÀÏÂ÷) : 2023-04-28
´ÙÀ½±Û ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷) : 2023-04-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 76 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 50 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 46 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 49 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 36 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 29 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷